Cargando…
Activation of diverse signaling pathways by oncogenic PIK3CA mutations
The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing ‘driver’ oncogenic mutations of PIK3CA to dissect the signaling mechanisms responsible for oncogenic phenotypes induced by mutan...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210192/ https://www.ncbi.nlm.nih.gov/pubmed/25247763 http://dx.doi.org/10.1038/ncomms5961 |
_version_ | 1782341341231972352 |
---|---|
author | Wu, Xinyan Renuse, Santosh Sahasrabuddhe, Nandini A. Zahari, Muhammad Saddiq Chaerkady, Raghothama Kim, Min-Sik Nirujogi, Raja S. Mohseni, Morassa Kumar, Praveen Raju, Rajesh Zhong, Jun Yang, Jian Neiswinger, Johnathan Jeong, Jun-Seop Newman, Robert Powers, Maureen A. Somani, Babu Lal Gabrielson, Edward Sukumar, Saraswati Stearns, Vered Qian, Jiang Zhu, Heng Vogelstein, Bert Park, Ben Ho Pandey, Akhilesh |
author_facet | Wu, Xinyan Renuse, Santosh Sahasrabuddhe, Nandini A. Zahari, Muhammad Saddiq Chaerkady, Raghothama Kim, Min-Sik Nirujogi, Raja S. Mohseni, Morassa Kumar, Praveen Raju, Rajesh Zhong, Jun Yang, Jian Neiswinger, Johnathan Jeong, Jun-Seop Newman, Robert Powers, Maureen A. Somani, Babu Lal Gabrielson, Edward Sukumar, Saraswati Stearns, Vered Qian, Jiang Zhu, Heng Vogelstein, Bert Park, Ben Ho Pandey, Akhilesh |
author_sort | Wu, Xinyan |
collection | PubMed |
description | The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing ‘driver’ oncogenic mutations of PIK3CA to dissect the signaling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signaling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signaling events and for discovering novel signaling molecules as readouts of pathway activation or potential therapeutic targets. |
format | Online Article Text |
id | pubmed-4210192 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
record_format | MEDLINE/PubMed |
spelling | pubmed-42101922015-03-23 Activation of diverse signaling pathways by oncogenic PIK3CA mutations Wu, Xinyan Renuse, Santosh Sahasrabuddhe, Nandini A. Zahari, Muhammad Saddiq Chaerkady, Raghothama Kim, Min-Sik Nirujogi, Raja S. Mohseni, Morassa Kumar, Praveen Raju, Rajesh Zhong, Jun Yang, Jian Neiswinger, Johnathan Jeong, Jun-Seop Newman, Robert Powers, Maureen A. Somani, Babu Lal Gabrielson, Edward Sukumar, Saraswati Stearns, Vered Qian, Jiang Zhu, Heng Vogelstein, Bert Park, Ben Ho Pandey, Akhilesh Nat Commun Article The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing ‘driver’ oncogenic mutations of PIK3CA to dissect the signaling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signaling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signaling events and for discovering novel signaling molecules as readouts of pathway activation or potential therapeutic targets. 2014-09-23 /pmc/articles/PMC4210192/ /pubmed/25247763 http://dx.doi.org/10.1038/ncomms5961 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Wu, Xinyan Renuse, Santosh Sahasrabuddhe, Nandini A. Zahari, Muhammad Saddiq Chaerkady, Raghothama Kim, Min-Sik Nirujogi, Raja S. Mohseni, Morassa Kumar, Praveen Raju, Rajesh Zhong, Jun Yang, Jian Neiswinger, Johnathan Jeong, Jun-Seop Newman, Robert Powers, Maureen A. Somani, Babu Lal Gabrielson, Edward Sukumar, Saraswati Stearns, Vered Qian, Jiang Zhu, Heng Vogelstein, Bert Park, Ben Ho Pandey, Akhilesh Activation of diverse signaling pathways by oncogenic PIK3CA mutations |
title | Activation of diverse signaling pathways by oncogenic PIK3CA mutations |
title_full | Activation of diverse signaling pathways by oncogenic PIK3CA mutations |
title_fullStr | Activation of diverse signaling pathways by oncogenic PIK3CA mutations |
title_full_unstemmed | Activation of diverse signaling pathways by oncogenic PIK3CA mutations |
title_short | Activation of diverse signaling pathways by oncogenic PIK3CA mutations |
title_sort | activation of diverse signaling pathways by oncogenic pik3ca mutations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210192/ https://www.ncbi.nlm.nih.gov/pubmed/25247763 http://dx.doi.org/10.1038/ncomms5961 |
work_keys_str_mv | AT wuxinyan activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT renusesantosh activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT sahasrabuddhenandinia activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT zaharimuhammadsaddiq activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT chaerkadyraghothama activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT kimminsik activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT nirujogirajas activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT mohsenimorassa activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT kumarpraveen activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT rajurajesh activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT zhongjun activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT yangjian activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT neiswingerjohnathan activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT jeongjunseop activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT newmanrobert activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT powersmaureena activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT somanibabulal activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT gabrielsonedward activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT sukumarsaraswati activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT stearnsvered activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT qianjiang activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT zhuheng activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT vogelsteinbert activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT parkbenho activationofdiversesignalingpathwaysbyoncogenicpik3camutations AT pandeyakhilesh activationofdiversesignalingpathwaysbyoncogenicpik3camutations |